Topics


Glioblastoma | Treatment | Clinical trials






Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials






□ OVERVIEW

□ UMBRELLA TRIALS









BIOMARKERS


□ EXTRACELL PARTICLES







CHEMOTHERAPY


□ CARBOPLATIN





□ DRUG DELIVERY





□ IRINOTECAN





□ LOMUSTINE

□ LURBINECTEDIN




□ METHOXYAMINE





□ NEOADJUVANT CHEMOTHER





□ R-(-)-GOSSYPOL





□ TAXANES

□ TEMOZOLOMIDE






DIAGNOSIS / ASSESSMENT


□ OLFACTORY FUNCTION

□ POSITRON EMISS TOMOGR






ELECTRIC / MAGNETIC FIELDS


□ TUMOR TREATING FIELDS







GENE THERAPY


□ AGLATIMAGENE BESADENOVEC







IMMUNOTHERAPY


□ BISPEC ANTIB ARM T CELLS





□ CAR-T-CELLS

□ CELL THERAPY




□ DENDRITIC CELLS





□ GM-CSF





□ IMMUNE CHECKP INHIBIT





□ mTOR INHIBITORS





□ VACCINES





□ VIRUSES







INTEGRATIVE MEDICINE


□ CIRCADIAN CLOCK





□ KETOGENIC METABOL THER





□ VITAMINS










LASER THERAPIES


□ LASER INTERST THERMAL THER










NUCLEAR MEDICINE


□ THERANOSTICS







PHARMACOTHERAPY


□ ANTIEMETIC DRUGS

□ ANTIEPILEPTIC DRUGS

□ ANTISECRETORY FACTOR

□ ARSENICALS


□ CHLOROTOXIN

□ CONTRACEPTIVE DRUGS




□ DISULFIRAM





□ IMMUNOSUPPR DRUGS







RADIOTHERAPY


□ BORON NEUTR CAPT THER





□ EXTERNAL BEAM RADIAT THER





□ FRACTIONATED





□ MARGINS





□ PHOTODYNAMIC THERAPY

□ PROTON BEAM




□ RADIOPHARMACEUTICALS

□ RADIOSENSITIZERS

□ RE-IRRADIATION

□ RESPONSE-ADAPTIVE




SIDE EFFECTS


□ THROMBOEMBOLISM










SUPPORTIVE CARE


□ PALLIATIVE CARE







SURGERY


□ BIOPSY





□ FLAIRECTOMY

□ FLUORESC-GUIDED SURG




□ RESECTION CAVITY

□ RESECTION EXTENT






TARGETED THERAPY


□ ADAVOSERTIB

□ AFATINIB

□ ALECTINIB

□ APTAMERS


□ ATEZOLIZUMAB





□ BEVACIZUMAB





□ DASATINIB

□ DRUG SCREENING




□ GLASDEGIB

□ GLUTAMATE SIGN INHIBIT




□ IDASANUTLIN

□ IDO1 INHIBITORS

□ IPILIMUMAB



□ KHK2455

□ KINASE INHIBITORS




□ LENVATINIB

□ LISAVANBULIN




□ MARIZOMIB

□ MICROENV MODULATORS

□ MOGAMULIZUMAB



□ NAVTEMADLIN

□ NIVOLUMAB




□ OLAPARIB





□ PALBOCICLIB

□ PAMIPARIB

□ PD-L1 TARGETED THERAPY

□ PEMBROLIZUMAB


□ PEXIDARTINIB





□ RINDOPEPIMUT

□ RO7428731




□ SACITUZUMAB GOVITECAN

□ SUNITINIB




□ TEMSIROLIMUS

□ TISLELIZUMAB




□ VAL-083

□ VELIPARIB

□ VISMODEGIB








ULTRASOUND THERAPY


□ FOCUSED ULTRASOUND







VARIANTS


□ MOLECULAR GLIOBLASTOMA